Skip Navigation Links
COVID Study Site
>
Review
>
Investigation
>
Vaccine Tracker
Skip Navigation Links
COVID Study Site
Review
Investigation
Treatment Tracker
Vaccine Tracker
SIR Model in Detail
My Work
My Website's Applications
My Thesis and Goals
My Model Representation
Country Classification
Data
Table View
Tests - Daily
Tests - Accumulated
Confirmed - Daily
Confirmed - Accumulated
Recovered - Daily
Recovered - Accumulated
Deaths - Daily
Deaths - Accumulated
Active - Daily
Active - Accumulated
Hospitalized - Daily
Hospitalized - Accumulated
Insights
Symptoms
Mortality Rate
Ratio Comparisons
Change over Time
Forecast
Statistics Model
SIR Model
Equation Model
About
Contact
Your Diagram Title
Covid 19 Vaccines → Phase 1: 10
Covid 19 Vaccines → Preclinical: 8
Covid 19 Vaccines → Phase 2: 6
Phase 2 → Moderna mRNA-1273: 3
Phase 2 → Sinovac: 3
Moderna mRNA-1273 → USA: 3
Sinovac → China: 3
Phase 1 → CanSino: 2
CanSino → China: 2
Phase 1 → Inovio: 2
Inovio → USA: 2
Phase 1 → University of Oxford: 2
University of Oxford → UK: 2
Phase 1 → BioNTech: 2
BioNTech → Germany: 2
Phase 1 → Novavax: 2
Novavax → USA: 2
Preclinical → Johnson & Johnson: 1
Johnson & Johnson → USA: 1
Preclinical → Arcturus: 1
Arcturus → USA: 1
Preclinical → Clover: 1
Clover → China: 1
Preclinical → CureVac: 1
CureVac → Germany: 1
Preclinical → Imperial College London: 1
Imperial College London → UK: 1
Preclinical → Sanofi and GlaxoSmithKline: 1
Sanofi and GlaxoSmithKline → France: 1
Preclinical → U Queensland and GlaxoSmithKline: 1
U Queensland and GlaxoSmithKline → UK: 1
Preclinical → Merck: 1
Merck → USA: 1
Moderna mRNA-1273: 3
Moderna mRNA-1273
Sinovac: 3
Sinovac
CanSino: 2
CanSino
Inovio: 2
Inovio
University of Oxford: 2
University of Oxford
BioNTech: 2
BioNTech
Novavax: 2
Novavax
Johnson & Johnson: 1
Johnson & Johnson
Arcturus: 1
Arcturus
Clover: 1
Clover
CureVac: 1
CureVac
Imperial College London: 1
Imperial College London
Sanofi and GlaxoSmithKline: 1
Sanofi and GlaxoSmithKline
U Queensland and GlaxoSmithKline: 1
U Queensland and GlaxoSmithKline
Merck: 1
Merck
Covid 19 Vaccines: 24
Covid 19 Vaccines
USA: 10
USA
UK: 4
UK
France: 1
France
China: 6
China
Germany: 3
Germany
Phase 2: 6
Phase 2
Phase 1: 10
Phase 1
Preclinical: 8
Preclinical